(CVAC) CureVac - Performance 16.4% in 12m
Compare CVAC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-80.52%
#138 in Group
Rel. Strength
81.10%
#1505 in Universe
Total Return 12m
16.44%
#33 in Group
Total Return 5y
-93.79%
#133 in Group
P/E 3.94
29th Percentile in Group
P/E Forward 5.24
23th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 57.8%
90th Percentile in Group
12m Total Return: CVAC (16.4%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CVAC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CVAC
Total Return (including Dividends) | CVAC | XBI | S&P 500 |
---|---|---|---|
1 Month | 16.44% | 2.02% | 2.87% |
3 Months | -6.47% | -15.44% | -6.42% |
12 Months | 16.44% | -14.02% | 9.87% |
5 Years | -93.79% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | CVAC | XBI | S&P 500 |
1 Month | 78.7% | 57% | 89.4% |
3 Months | 1.10% | -82.3% | -72% |
12 Months | -20.4% | -53.1% | 49.3% |
5 Years | -95.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #28 | 14.1% | 13.2% |
3 Month | #50 | 10.6% | -0.06% |
12 Month | #35 | 35.4% | 5.98% |
5 Years | #130 | -91.1% | -96.5% |
FAQs
Does CVAC CureVac outperforms the market?
Yes,
over the last 12 months CVAC made 16.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months CVAC made -6.47%, while XBI made -15.44%.
Over the last 3 months CVAC made -6.47%, while XBI made -15.44%.
Performance Comparison CVAC vs Indeces and Sectors
CVAC vs. Indices CVAC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.10% | 13.6% | 29.5% | 6.57% |
US NASDAQ 100 | QQQ | -2.35% | 11.7% | 29.1% | 5.12% |
US Dow Jones Industrial 30 | DIA | -2.38% | 14.8% | 30.6% | 10.1% |
German DAX 40 | DAX | -4.22% | -2.84% | 3.94% | -8.64% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.76% | 10.2% | 30.3% | 10.8% |
Hongkong Hang Seng | HSI | -5.62% | 0.23% | 20.0% | 4.35% |
India NIFTY 50 | INDA | 0.29% | 14.2% | 27.6% | 14.1% |
Brasil Bovespa | EWZ | -4.15% | 4.91% | 20.3% | 22.9% |
CVAC vs. Sectors CVAC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.28% | 12.8% | 23.3% | -3.89% |
Consumer Discretionary | XLY | -3.02% | 12.9% | 31.7% | 2.39% |
Consumer Staples | XLP | -1.73% | 14.4% | 22.6% | 8.88% |
Energy | XLE | -3.08% | 16.4% | 35.5% | 26.2% |
Financial | XLF | -2.73% | 10.9% | 23.6% | -5.08% |
Health Care | XLV | 1.69% | 20.8% | 34.8% | 22.4% |
Industrial | XLI | -3.67% | 9.06% | 28.5% | 6.45% |
Materials | XLB | -2.09% | 11.7% | 33.6% | 22.5% |
Real Estate | XLRE | -1.77% | 10.3% | 27.1% | 2.98% |
Technology | XLK | -2.99% | 9.70% | 31.8% | 9.44% |
Utilities | XLU | -3.14% | 10.8% | 21.8% | 0.53% |
Aerospace & Defense | XAR | -2.61% | 7.10% | 20.2% | -8.72% |
Biotech | XBI | 5.98% | 14.4% | 50.6% | 30.5% |
Homebuilder | XHB | -1.66% | 13.4% | 43.2% | 26.2% |
Retail | XRT | -2.25% | 12.9% | 35.8% | 20.8% |